Cardiovascular Systems, Inc. Announces Pricing of Public Offering of Common Stock

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (“CSI”) (Nasdaq:CSII - News), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced the pricing of an underwritten public offering of 1,780,000 shares of its common stock, at a price to the public of $9.00 per share. The net proceeds to CSI from the sale of the shares, after deducting underwriting discounts and commissions and estimated expenses, are expected to be approximately $15.0 million. All of the shares in the offering are to be sold by CSI. The offering is expected to close on or about May 25, 2012.

Back to news